We are delighted to announce the appointment of Stephen Over as the Company's Chief Financial Officer and new member of the Executive team.
Stephen brings a wealth of senior leadership and strategic financing expertise with over 10 years of experience in the pharmaceuticals, biotech and medical devices industries.
NeoPhore appoints Michael Shih as Chief Executive Officer • Highly experienced corporate development leader with a track record of international p…
NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb Additional funding will be used to explore…
The NeoPhore team attended the American Association for Cancer Research Annual Meeting in San Diego, 5 - 10 April 2024. In collaboration with The…